Dr. Yvonne Lynnette Carter, MD

Dr. Carter practices at Atrium Health Cabarrus in Concord, North Carolina, part of Advocate Health.

Dr. Carter's NPI, 1386788776, was assigned on February 18, 2007. Dr. Carter graduated from University of Maryland School of Medicine - Baltimore in 2004. Dr. Carter holds North Carolina license 2007-00271.

Dr. Carter's primary practice is Atrium Health Cabarrus, at 920 Church St N, Concord, NC 28025 in Cabarrus County. The practice phone is (704) 783-3000.

Dr. Carter's primary practice is Atrium Health Cabarrus in Concord, North Carolina, part of Advocate Health. Dr. Carter is also affiliated with Atrium Health Carolinas Medical Center. The medical group on file is Atrium Health Cleveland Imaging. Dmand AI also links Dr. Carter to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Carter practices, 6 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Carter's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Carter is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Carter's licenses on file in 2 states: North Carolina and Georgia.

Dmand AI lists acute skin infection, hiv/aids, joint or bone infection and pneumonia among the conditions Dr. Carter treats.

CMS data shows 492 Medicare services from Dr. Carter across 6 procedure codes in 2024, for 192 Medicare patients. Medicare paid $36,318 for them.

CMS counts 192 Medicare patients who saw Dr. Carter in 2024. The largest group is 65 to 74, with 67 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 3.13, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Carter's median patient age at 71, with 44% women.

In 2024, Dr. Carter wrote 477 Medicare Part D claims for 82 patients. 65% of them were for generic drugs. CMS names the drug for 369 of them, across 18 drugs with 11 or more claims each, at $441,129 in total drug cost. In 2023, CMS named 405 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Carter for performance year 2024, reported as part of a group. Dr. Carter accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Carter as offering telehealth.

Dmand AI links 8 papers to Dr. Carter, published from 2012 to 2020. The most frequent topics are Infection Control, London and United Kingdom. Dr. Carter has published most often in Nurs Times. Dr. Carter's most frequent co-authors are Yvonne Marie Carter, MD, John D. Christie, MD, PhD and Ian Bebvon Kuwait Martin, MD.

CMS Open Payments shows 106 general payments to Dr. Carter from 7 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Janssen Pharmaceuticals, Inc paid the most, $1,108.

Dr. Carter graduated from University of Maryland School of Medicine - Baltimore in 2004.

Dr. Carter is in network with 20 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 10. Check the plan with the practice before a visit.